BỆNH VIÊM DA DO Demodex spp. GÂY RA TRÊN CHÓ TẠI TỈNH THÁI NGUYÊN VÀ HIỆU QUẢ ĐIỀU TRỊ BỆNH
Thông tin bài báo
Ngày nhận bài: 23/11/25                Ngày hoàn thiện: 24/06/26                Ngày đăng: 25/06/26Tóm tắt
Từ khóa
Toàn văn:
PDFTài liệu tham khảo
[1] D. W. Scott, W. H. Miller, and C. E. Griffin, “Griffin Demodicosis in Dogs,” Journal of Veterinary Dermatology, vol. 12, no. 5, pp. 223-230, 2001.
[2] R. Sakulploy and A. Sangvaranond, “Clinical observation of demodicosis in dogs,” Journal of Veterinary Dermatology, vol. 21(Supplement 1), 2010, Art. no. 42.
[3] T. H. P. Phan, V. C. La, N. T. Tran, and T. A. T. Nguyen, “Some epidemiological characteristics of Demodex canis disease in service dogs raised at Border Guard Intermediate School 24 and treatment regimen,” (in Vietnamese), TNU Journal of Science and Technology, vol. 202, no. 09, pp. 129-133, 2019.
[4] C. M. Noli and L. S. Scasciotti, “Pathogenesis of canine demodicosis,” Veterinary Journal, vol. 206, no. 1, pp. 20-25, 2015.
[5] R. S. Mueller, E. Bensignor, L. Ferrer, B. Holm, S. Lemarié, M. Paradis, and M. Shipstone, “Treatment of demodicosis in dogs: 2011 clinical practice guidelines,” Journal of Veterinary Dermatology, vol. 23, no. 4, pp. 234-244, 2012.
[6] F. Beugnet, L. Halos, D. Larsen, and C. De Vos, “Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis,” Parasite, vol. 23, 2016, Art. no. 14.
[7] R. Steffen, D. V. Christa, C. B. Frédéric, S. C. Doug, and J. F. Josephus, “Efficacy of Once-Monthly Doses of Oral Afoxolaner and Afoxolaner/Milbemycin Oxime in a Well-Controlled Study for the Treatment of Canine Generalized Demodicosis,” Open Journal of Veterinary Medicine, vol. 8, pp. 250-265, 2018.
[8] K. P. Van and L. Phan, Veterinary Parasitology. Agricultural Publishing House, (in Vietnamese), Hanoi, 1996, pp. 191-193.
[9] D. H. Tran, T. H. G. Nguyen, T. H. Ho, V. D. Nguyen, and N. S. Ta, “Study on several epidemiological characteristics of scabies disease in dogs in Vinh city, Nghe An province,” (in Vietnamese), Journal of Veterinary Science and Technology, vol. XXVI, no. 8, pp. 63-70, 2019.
[10] R. S. Mueller, D. Meyer, E. Bensignor, and S. C. Louis, “Treatment of canine generalized demodicosis with a ‘spot-on’formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate®, Bayer Healthcare),” Veterinary Dermatology, vol. 20, no. 5-6, pp. 441-446, 2009.
[11] A. Kumar, R. K. Sinha, R. Tiwary, and N. Kumari, “Clinical management of frustrating canine generalized demodecosis in a female germansephard dog: A case report,” The Pharma Innovation J., vol. 7, pp. 634-636, 2018.
[12] N. M. Le, T. A. D. Tran, N. B. Tran, T. N. M. Luu, T. T. Dang, and T. G. Huynh, “Study on diseases caused by Demodex canis in dogs at Bao Minh Chau Veterinary clinic, Can Tho city,” (in Vietnamese), Journal of Veterinary Science and Technology, vol. XXX, no. 3, pp. 87-91, 2023.
[13] J. S. Ettinger and E. C. Feldman, Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat, vol. 2, 8th Edition. Elsevier, 2017, pp. 416-436.
[14] M. C. Cury, D. D. Silva, and A. P. Santos, “Hematological and clinical changes in dogs with generalized demodicosis,” in Veterinary Parasitology. Elsevier, 2021, p. 290.
[15] M. Goto, S. Yamamoto, and H. Ogawa, “Hematological and serum biochemical findings in canine demodicosis,” Journal of Veterinary Medical Science, vol. 64, no. 8, pp. 745-748, 2002.DOI: https://doi.org/10.34238/tnu-jst.14066
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu





